NEWS

Treating a right ICA aneurysm using an EVOLVE flow diverter

An unusual case of stroke

Cerus Endovascular and Balt Enter Strategic Distribution Agreement for I...

FREMONT, Calif. and OXFORD, United Kingdom and MONTMORENCY, France, Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company and AB Medica Deutschland Verwaltungs GmbH, a wholly owned subsidiary of Balt, today announced that they have entered into a strategic distribution agreement providing AB Medica with the exclusive rights to market and sell the newly CE marked Contour Neurovascular System™ and the Neqstent Coil Assisted Flow Diverter devices in Germany. Terms of the agreement were not disclosed.

Cerus Endovascular Receives CE Mark Approval for its CerusEndo MC 021 Mi...

Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020

Silk Vista "Mama" 1st case experience

XCalibur AOD in treatment of direct carotid cavernous fistula

Intracranial haemorrhage 18 years after cranial trauma

The LINNC Agenda for 2020 is finally set!

COVI-LINNC roundtable: epidemic situation in Chile

COVI-LINNC roundtable: epidemic situation in Iran